Suven Pharmaceuticals Limited (SUVENPHAR) — Cash Flow Reinvestment Rate
Suven Pharmaceuticals Limited (SUVENPHAR) has a Cash Flow Reinvestment Rate of 0.00x as of December 2023, reinvesting Rs0.00 (capex Rs0.00 ) from operating cash flow of Rs255.04 Million. Explore Suven Pharmaceuticals Limited capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Suven Pharmaceuticals Limited Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Suven Pharmaceuticals Limited across 7 annual periods. Also explore balance sheet size of Suven Pharmaceuticals Limited for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Suven Pharmaceuticals Limited (2019–2025)
Year-by-year capital reinvestment analysis for Suven Pharmaceuticals Limited. For live market cap and broader valuation context, see SUVENPHAR company net worth.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.43x | Rs4.11 Billion | Rs2.88 Billion | Rs1.56 Billion | ▲ +23.5% |
| 2024 | 1.15x | Rs4.14 Billion | Rs3.58 Billion | Rs517.87 Million | ▲ +8.4% |
| 2023 | 1.07x | Rs4.81 Billion | Rs4.51 Billion | Rs2.86 Billion | ▲ +168.0% |
| 2022 | 0.40x | Rs1.31 Billion | Rs3.30 Billion | Rs751.87 Million | ▼ -51.0% |
| 2021 | 0.81x | Rs3.11 Billion | Rs3.83 Billion | Rs1.11 Billion | ▼ -20.4% |
| 2020 | 1.02x | Rs4.25 Billion | Rs4.16 Billion | Rs994.15 Million | ▼ -29.9% |
| 2019 | 1.46x | Rs733.40 Million | Rs504.05 Million | Rs567.86 Million | — |